Cargando…

A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD

Aims: It remains controversial to choose the optimal equation to estimate glomerular filtration rate (GFR) in chronic kidney disease (CKD) patients with diabetes. Materials and Methods: Two hundred and fifteen diabetic CKD patients and 192 non-diabetic CKD patients were enrolled in this study. Iohex...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Danshu, Shi, Hao, Xie, Jingyuan, Ding, Ying, Zhang, Wen, Ni, Liyan, Wu, Yifan, Lu, Yimin, Chen, Bing, Wang, Hongrui, Ren, Hong, Wang, Weiming, Liu, Na, Chen, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718123/
https://www.ncbi.nlm.nih.gov/pubmed/31507533
http://dx.doi.org/10.3389/fendo.2019.00581
_version_ 1783447686539640832
author Xie, Danshu
Shi, Hao
Xie, Jingyuan
Ding, Ying
Zhang, Wen
Ni, Liyan
Wu, Yifan
Lu, Yimin
Chen, Bing
Wang, Hongrui
Ren, Hong
Wang, Weiming
Liu, Na
Chen, Nan
author_facet Xie, Danshu
Shi, Hao
Xie, Jingyuan
Ding, Ying
Zhang, Wen
Ni, Liyan
Wu, Yifan
Lu, Yimin
Chen, Bing
Wang, Hongrui
Ren, Hong
Wang, Weiming
Liu, Na
Chen, Nan
author_sort Xie, Danshu
collection PubMed
description Aims: It remains controversial to choose the optimal equation to estimate glomerular filtration rate (GFR) in chronic kidney disease (CKD) patients with diabetes. Materials and Methods: Two hundred and fifteen diabetic CKD patients and 192 non-diabetic CKD patients were enrolled in this study. Iohexol GFR, serum creatinine (SCr), and Cystatin C(CysC) were measured simultaneously for each patient. SCr- and CysC-based estimated GFR (eGFR) were calculated through eight equations, including three CKD-EPI equations, Revised Lund-Malmö study equation (RLM), CAPA equation, and three Full Age Spectrum (FAS) equations. Bias, precision, and accuracy were compared among eGFR equations with iohexol-GFR serving as measured GFR (mGFR). Independent predictive factors of accuracy were explored using multivariate logistic regression analysis. Results: In the diabetic group, CKD-EPI(SCr−CysC) showed the best performance among three CKD-EPI equations (interquartile range of 13.88 ml/min/1.73 m(2) and 30% accuracy of 72.56%). Compared to CKD-EPI(SCr−CysC), the other five equations did not significantly improve the performance of GFR estimates. Mostly, eGFR equations were less accurate in diabetic group than in non-diabetic group. Significant differences were found in different mGFR range (P < 0.001). The multivariate logistic regression analysis identified that BMI, mGFR, and diabetic kidney disease (DKD) status were independent predictors of accuracy of three equations in diabetic group. HbA1c was a predictor of accuracy of CKD-EPI(SCr) and CKD-EPI(CysC) in diabetic group. Conclusions: This study showed that eGFR equations were less accurate in the diabetic group than in the non-diabetic group. CKD-EPI(Scr−CysC) had the best performance among CKD-EPI equations in Chinese diabetic CKD patients. The other five equations did not significantly improve the performance of GFR estimates. BMI, mGFR, DKD status, and HbA1c were independent factors associated with accuracy in eGFR equations.
format Online
Article
Text
id pubmed-6718123
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67181232019-09-10 A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD Xie, Danshu Shi, Hao Xie, Jingyuan Ding, Ying Zhang, Wen Ni, Liyan Wu, Yifan Lu, Yimin Chen, Bing Wang, Hongrui Ren, Hong Wang, Weiming Liu, Na Chen, Nan Front Endocrinol (Lausanne) Endocrinology Aims: It remains controversial to choose the optimal equation to estimate glomerular filtration rate (GFR) in chronic kidney disease (CKD) patients with diabetes. Materials and Methods: Two hundred and fifteen diabetic CKD patients and 192 non-diabetic CKD patients were enrolled in this study. Iohexol GFR, serum creatinine (SCr), and Cystatin C(CysC) were measured simultaneously for each patient. SCr- and CysC-based estimated GFR (eGFR) were calculated through eight equations, including three CKD-EPI equations, Revised Lund-Malmö study equation (RLM), CAPA equation, and three Full Age Spectrum (FAS) equations. Bias, precision, and accuracy were compared among eGFR equations with iohexol-GFR serving as measured GFR (mGFR). Independent predictive factors of accuracy were explored using multivariate logistic regression analysis. Results: In the diabetic group, CKD-EPI(SCr−CysC) showed the best performance among three CKD-EPI equations (interquartile range of 13.88 ml/min/1.73 m(2) and 30% accuracy of 72.56%). Compared to CKD-EPI(SCr−CysC), the other five equations did not significantly improve the performance of GFR estimates. Mostly, eGFR equations were less accurate in diabetic group than in non-diabetic group. Significant differences were found in different mGFR range (P < 0.001). The multivariate logistic regression analysis identified that BMI, mGFR, and diabetic kidney disease (DKD) status were independent predictors of accuracy of three equations in diabetic group. HbA1c was a predictor of accuracy of CKD-EPI(SCr) and CKD-EPI(CysC) in diabetic group. Conclusions: This study showed that eGFR equations were less accurate in the diabetic group than in the non-diabetic group. CKD-EPI(Scr−CysC) had the best performance among CKD-EPI equations in Chinese diabetic CKD patients. The other five equations did not significantly improve the performance of GFR estimates. BMI, mGFR, DKD status, and HbA1c were independent factors associated with accuracy in eGFR equations. Frontiers Media S.A. 2019-08-26 /pmc/articles/PMC6718123/ /pubmed/31507533 http://dx.doi.org/10.3389/fendo.2019.00581 Text en Copyright © 2019 Xie, Shi, Xie, Ding, Zhang, Ni, Wu, Lu, Chen, Wang, Ren, Wang, Liu and Chen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Xie, Danshu
Shi, Hao
Xie, Jingyuan
Ding, Ying
Zhang, Wen
Ni, Liyan
Wu, Yifan
Lu, Yimin
Chen, Bing
Wang, Hongrui
Ren, Hong
Wang, Weiming
Liu, Na
Chen, Nan
A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD
title A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD
title_full A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD
title_fullStr A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD
title_full_unstemmed A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD
title_short A Validation Study on eGFR Equations in Chinese Patients With Diabetic or Non-diabetic CKD
title_sort validation study on egfr equations in chinese patients with diabetic or non-diabetic ckd
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718123/
https://www.ncbi.nlm.nih.gov/pubmed/31507533
http://dx.doi.org/10.3389/fendo.2019.00581
work_keys_str_mv AT xiedanshu avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT shihao avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT xiejingyuan avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT dingying avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT zhangwen avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT niliyan avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT wuyifan avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT luyimin avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT chenbing avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT wanghongrui avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT renhong avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT wangweiming avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT liuna avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT chennan avalidationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT xiedanshu validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT shihao validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT xiejingyuan validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT dingying validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT zhangwen validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT niliyan validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT wuyifan validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT luyimin validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT chenbing validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT wanghongrui validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT renhong validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT wangweiming validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT liuna validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd
AT chennan validationstudyonegfrequationsinchinesepatientswithdiabeticornondiabeticckd